Abstract:Background and Purpose: The incidence and prevalence of autoimmune encephalitis is gradually increasing. This retrospective observational study primarily aimed to analyze the clinical characteristics of autoimmune encephalitis patients in the Second Xiangya Hospital and report patient prognoses after immunotherapy.Methods: The clinical data of 86 patients who were diagnosed with autoimmune encephalitis from October 2014 to September 2018 were collected, and their corresponding clinical characteristics, laboratory examination, treatment, and outcome data analyzed.Results: In our study, 72 patients (83.7%) were positive for anti-NMDAR (N-methyl-D-aspartate receptor) antibody; 5 patients (6%) for anti-GABABR (γ-aminobutyric acid receptor-A); 4 patients (4.7%) for anti-LGI1 (leucine-rich, glioma inactivated 1); 3 patients (3.5%) for anti-Caspr2 (contactin-associated protein-like 2) (1 patient was positive for both anti-LGI1 and anti-Caspr2 antibodies); and 3 patients (3.5%) for onconeural antibodies. Among the 86 patients diagnosed as having autoimmune encephalitis, 50% showed acute disease onset (≤2 weeks). The most common inducing factor was fever or cold (17/86, 19.8%). The main clinical symptoms included, among others, psychiatric disturbances (82.5%), epilepsy (60.5%), autonomic dysfunction (58.1%), sleep disorders (45.3%), consciousness disorders (45.3%), and speech disorders (46.5%). No significant correlation between ICU admission rates and CSF or serum antibody scores was observed. However, CSF antibody scores of (+ + +) and (++) were associated with longer lengths of hospitalization (p < 0.05) and a higher CSF WBC count when compared with CSF antibody scores of (+) in patients with anti-NMDAR encephalitis (p < 0.05). Additionally, there was no significant correlation between mRS score difference on admission and discharge (after immunotherapy) and age, sex, and choice of immune treatment, while immune therapy taken within 15 days from onset was more inclined to be associated with an mRS score difference ≥2 after immunotherapy in patients with anti-NMDAR encephalitis (p = 0.006).Conclusions: Autoimmune encephalitis has an acute or sub-acute onset and presents with psychotic symptoms, epilepsy, and autonomic dysfunction. The sex ratio in anti-NMDAR encephalitis was nearly balanced. Infection was a major factor inducing anti-NMDAR encephalitis, and the CSF antibody scores could be helpful in determining its prognosis since these scores showed associations with hospitalization duration and CSF WBC counts.

Clinical characteristics of autoimmune encephalitis with co-existence of multiple anti-neuronal antibodies

Coexistence of multiple anti-neuronal antibodies in autoimmune encephalitis in China: A multi-center study

Autoimmune encephalitis with coexisting antibodies to GABABR, GAD65, SOX1 and Ma2

Two Cases of Autoimmune Encephalitis with Multiple Anti-neuronal Antibodies

Identification of Anti-Collapsin Response Mediator Protein 2 Antibodies in Patients with Encephalitis or Encephalomyelitis

Coexistence of anti-NMDAR and anti-IgLON5 antibodies in an autoimmune encephalitis patient: The first case report

Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases

Autoimmune encephalitis with coexistent LGI1 and GABABR1 antibodies: case report

Neuronal Surface Antibody-Medicated Autoimmune Encephalitis (Limbic Encephalitis) in China: A Multiple-Center, Retrospective Study

Characteristics and Prognosis of Autoimmune Encephalitis in the East of China: A Multi-Center Study

Clinical features, cerebrospinal fluid changes, and prognosis in Chinese patients with autoimmune encephalitis

Anti-adenylate Kinase 5 Encephalitis: Clinical Characteristics, Diagnosis, and Management of This Rare Entity

Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody–associated encephalomyelitis: a case report and review of the literature

Autoimmune encephalitis antibody profiles and clinical characteristics of children with suspected autoimmune encephalitis

A case of GFAP-IgG positivity followed by anti-NMDAR encephalitis

Clinical Characteristics and Short-Term Prognosis of Autoimmune Encephalitis: A Single-Center Cohort Study in Changsha, China

Clinical features and immunotherapy outcomes in antibody-negative autoimmune encephalitis: a retrospective case-control study

Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review

Analysis of Clinical Characteristics of Autoimmune Encephalitis: 17 Cases Report

Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously

A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies